L Belli

6.9k total citations
174 papers, 3.1k citations indexed

About

L Belli is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, L Belli has authored 174 papers receiving a total of 3.1k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Hepatology, 79 papers in Epidemiology and 59 papers in Surgery. Recurrent topics in L Belli's work include Liver Disease Diagnosis and Treatment (64 papers), Liver Disease and Transplantation (63 papers) and Hepatitis C virus research (47 papers). L Belli is often cited by papers focused on Liver Disease Diagnosis and Treatment (64 papers), Liver Disease and Transplantation (63 papers) and Hepatitis C virus research (47 papers). L Belli collaborates with scholars based in Italy, United States and France. L Belli's co-authors include Luciano De Carlis, G. F. Rondinara, D Forti, Paolo Aseni, Claudio Zavaglia, Alberto B. Alberti, C. V. Sansalone, Mario Strazzabosco, Giovambattista Pinzello and Patrizia Burra and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of the American Society of Nephrology.

In The Last Decade

L Belli

156 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L Belli Italy 33 2.3k 1.5k 1.3k 297 256 174 3.1k
Christian Ducerf France 29 2.2k 1.0× 1.5k 1.0× 1.8k 1.4× 379 1.3× 478 1.9× 138 3.5k
Russell H. Wiesner United States 28 2.3k 1.0× 2.2k 1.5× 1.7k 1.3× 440 1.5× 658 2.6× 60 4.0k
David Mayer United Kingdom 29 1.7k 0.7× 717 0.5× 1.9k 1.5× 511 1.7× 419 1.6× 96 3.1k
Vijayan Balan United States 27 1.5k 0.6× 1.1k 0.8× 732 0.6× 122 0.4× 136 0.5× 63 2.3k
Susan L. Orloff United States 32 966 0.4× 1.5k 1.0× 967 0.8× 266 0.9× 268 1.0× 118 2.7k
Andrew P. Keaveny United States 28 1.9k 0.8× 1.2k 0.8× 1.3k 1.0× 353 1.2× 138 0.5× 118 2.6k
Surakit Pungpapong United States 27 1.0k 0.5× 1.2k 0.8× 978 0.8× 183 0.6× 490 1.9× 103 2.3k
Laura Lladó Spain 27 1.4k 0.6× 836 0.6× 1.5k 1.2× 313 1.1× 569 2.2× 151 2.6k
I. J. Klompmaker Netherlands 28 910 0.4× 718 0.5× 1.0k 0.8× 269 0.9× 264 1.0× 61 2.0k
Todd K. Howard United States 28 2.7k 1.2× 2.2k 1.5× 2.8k 2.2× 886 3.0× 361 1.4× 92 4.8k

Countries citing papers authored by L Belli

Since Specialization
Citations

This map shows the geographic impact of L Belli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L Belli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L Belli more than expected).

Fields of papers citing papers by L Belli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L Belli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L Belli. The network helps show where L Belli may publish in the future.

Co-authorship network of co-authors of L Belli

This figure shows the co-authorship network connecting the top 25 collaborators of L Belli. A scholar is included among the top collaborators of L Belli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L Belli. L Belli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Aseni, Paolo, Maurizio Vertemati, Chiara Becchetti, et al.. (2025). Safety and Efficacy of Portal Vein Recanalization with Creation of Intrahepatic Portosystemic Shunt (PVR-TIPS) to Treat Chronic Portal Vein Thrombosis in Non-cirrhotic Patients. CardioVascular and Interventional Radiology. 48(3). 351–361.
2.
Maira, Tommaso Di, Valérie Cailliez, Beatriz Domínguez‐Gil, et al.. (2025). Regional variations and trends in liver transplantation practices across Europe. JHEP Reports. 7(8). 101424–101424.
3.
4.
Carbone, Marco, Chiara Mazzarelli, Eléonora De Martin, et al.. (2023). Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement. Transplant International. 36. 11729–11729. 8 indexed citations
5.
6.
Marjot, Thomas, Christiane S. Eberhardt, Tobias Boettler, et al.. (2022). Impact of COVID-19 on the liver and on the care of patients with chronic liver disease, hepatobiliary cancer, and liver transplantation: An updated EASL position paper. Journal of Hepatology. 77(4). 1161–1197. 43 indexed citations
7.
Germani, Giacomo, Alberto Zanetto, René Adam, et al.. (2020). Influence of donor and recipient gender on liver transplantation outcomes in Europe. Liver International. 40(8). 1961–1971. 29 indexed citations
8.
Ferrarese, Alberto, Maria Cristina Morelli, Paola Carrai, et al.. (2020). Outcomes of Liver Transplant for Adults With Wilson’s Disease. Liver Transplantation. 26(4). 507–516. 14 indexed citations
9.
Burra, Patrizia, L Belli, Stefano Ginanni Corradini, et al.. (2017). Common issues in the management of patients in the waiting list and after liver transplantation. Digestive and Liver Disease. 49(3). 241–253. 18 indexed citations
10.
Carbone, Marco, Laura Cristoferi, Paolo Angelo Cortesi, et al.. (2017). Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(4). 1415–1422. 3 indexed citations
11.
Mancuso, Andrea, Alessandra Mazzola, Giuseppe Cabibbo, et al.. (2015). Survival of patients treated with sorafenib for hepatocellular carcinoma recurrence after liver transplantation: A systematic review and meta-analysis. Digestive and Liver Disease. 47(4). 324–330. 46 indexed citations
12.
Cortesi, Paolo Angelo, L Scalone, G Cesana, et al.. (2014). A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases. Value in Health. 17(7). A369–A369. 2 indexed citations
13.
Okolicsanyi, S., Manuel Gentiluomo, Paolo Angelo Cortesi, et al.. (2013). Generation and Performance of Outcome Indicators in Liver Disease: The Value Based Medicine in Hepatology Study (VBMH). Hepatology. 58. 2 indexed citations
14.
Vitale, Alessandro, Michael L. Volk, Tullia Maria De Feo, et al.. (2013). A method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common liver transplant waiting list. Journal of Hepatology. 60(2). 290–297. 77 indexed citations
15.
Scalone, L, Paolo Angelo Cortesi, Roberta Ciampichini, et al.. (2012). PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases. Value in Health. 15(7). A332–A332. 1 indexed citations
16.
Belli, L, Peter Stärkel, Riccardo Volpes, et al.. (2009). Peg-ifn-alfa 2b With Ribavirin for the Treatment of Mild-moderate Recurrent Hepatitis C After Liver Transplantation (lt) : Impact On Fibrosis Progression. a Multicenter Randomized Controlled Study. Hepatology. 50(4). 192–192. 1 indexed citations
17.
Fea, Antonio Maria, et al.. (2004). Is contrast sensitivity of POAG patients getting better with cyticholine treatment. Investigative Ophthalmology & Visual Science. 45(13). 901–901.
18.
Gozzetti, G, L Belli, Lorenzo Capussotti, et al.. (1992). Liver resection for hepatocellular carcinoma in cirrhotic patients.. PubMed. 24(2). 105–10. 12 indexed citations
19.
Romani, F, et al.. (1992). Liver transplantation for small HCC in cirrhosis. PubMed. 5 Suppl 1. 215–216. 3 indexed citations
20.
Aseni, Paolo, Cédric Beau, Maurizio Vertemati, Anna Meroni, & L Belli. (1987). Liver Arterialization Prevents Thrombocytopenia after Portacaval Shunt in Rats. European Surgical Research. 19(3). 159–163. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christian Ducerf Breakdown of academic impact, for papers by Russell H. Wiesner Breakdown of academic impact, for papers by David Mayer Breakdown of academic impact, for papers by Vijayan Balan Breakdown of academic impact, for papers by Susan L. Orloff Breakdown of academic impact, for papers by Andrew P. Keaveny Breakdown of academic impact, for papers by Surakit Pungpapong Breakdown of academic impact, for papers by Laura Lladó Breakdown of academic impact, for papers by I. J. Klompmaker Breakdown of academic impact, for papers by Todd K. Howard
Rankless by CCL
2026